Clin2
NCT02961413Possibly a fitRecruiting

Study of drug-related liver injury in China

Drug-induced Liver Injury

Part of Digestive system clinical trials.

This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
Any age
Study type
Observational

Who can take part

  • You have liver injury caused by a medicine (drug-induced liver injury), not another cause
  • Your diagnosis fits China’s 2015 drug-induced liver injury guidelines
  • Your likelihood score (RUCAM) is 6 or higher, or between 3–5 if three experts agree the medicine caused it
  • You can understand the study and sign an informed consent form
  • Your liver problem is not due to causes other than medicines (for example, not non-drug causes)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05060289Recruiting
Predicting drug-related liver injury using blood tests and expert review

This trial builds a prediction model to identify drug-related liver injury (DILI) by looking at your blood test patterns, timing, and expert diagnosis. It may help improve how doctors recognize this condition earlier and more accurately.

Beijing, Beijing Municipality
NCT06771011Recruiting
Comparing two ways to diagnose liver injury causes

This study compares two methods (RUCAM and RECAM) to better identify what caused a recent liver injury. It may help doctors find the right cause and treatment faster.

Beijing, Beijing Municipality
NCT00360646Recruiting
Share records for a drug-related liver injury research registry

This study puts people with a past drug- or herbal-related liver injury into a research registry. The goal is to better understand why the injury happens so doctors can prevent and recognize it sooner.

Los Angeles, California
NCT06446609Recruiting
Itching in drug-induced liver injury study

This study looks at itching caused by drug-induced liver injury. Researchers want to understand who gets itchy and how bad it is, which could help improve care for people with this condition.

Nottingham
NCT06922669Recruiting
Steroids for drug-induced liver injury with high bilirubin

This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.

Shenyang, Liaoning
NCT04964310Recruiting
Testing genetic risk for acetaminophen-related liver injury

This study looks at whether certain genes can predict who is more likely to get liver injury after taking acetaminophen (also found in some cold/flu medicines). By comparing people who were affected with people who were not, it may help doctors identify higher-risk patients in the future.

Nanjing, Jiangsu

Hear when a new Drug Induced Liver Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.